Future trends in prostate cancer theranostics with PSMA ligands
Crossref DOI link: https://doi.org/10.1007/s40336-016-0184-9
Published Online: 2016-07-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haberkorn, Uwe
Kopka, Klaus
Giesel, Frederik
Kratochwil, Clemens
License valid from 2016-07-14